[EN] BENZOFUROPYRIMIDINONES AS PROTEIN KINASE INHIBITORS<br/>[FR] BENZOFUROPYRIMIDINONES EN TANT QU'INHIBITEURS DE PROTÉINE KINASE
申请人:EXELIXIS INC
公开号:WO2009086264A1
公开(公告)日:2009-07-09
A compound according to formula I: or a pharmaceutically acceptable salt thereof; wherein R1, R2, R3a, R3b, R3c and R3d are as defined in the specification, pharmaceutical compositions thereof, and methods of use thereof.
C- ARYL GLYCOSID DERIVATIVES, PHARMACEUTICAL COMPOSITION, PREPARATION PROCESS AND USES THEREOF
申请人:SHANGHAI DE NOVO PHARMATECH CO. LTD.
公开号:US20170037038A1
公开(公告)日:2017-02-09
This invention relates to a kind of C-aryl glycoside derivatives, its pharmaceutical compositions, preparation methods, and uses thereof. The preparation method comprises: method 1: in a solvent, deprotecting the acetyl protecting groups of compound 1-f in the presence of a base; method 2: 1) compound 2-g reacts with
via Mitsunobu reaction; 2) deprotecting the acetyl protecting groups of compound 2-f obtained from step 1; method 3: 1) compound 2-g reacts with
via nucleophilic substitution reaction; 2) deprotecting the acetyl protecting groups of compound 3-f obtained from step 1. The pharmaceutical composition comprises a kind of C-aryl glycoside derivatives; it's pharmaceutically acceptable salts and/or prodrugs thereof and excipient thereof. This invention further relates to a kind of C-aryl glycoside derivatives, it's pharmaceutically acceptable salts or pharmaceutical compositions thereof for the use in preparation of a SGLT inhibitor. The C-aryl glycoside derivatives of this invention provides a new direction for the study of SGLT inhibitors.
Pd-catalyzed intramolecular Heck reaction for the synthesis of 2-methylbenzofurans
作者:Lixin Zhou、Yuxing Shi、Xueyan Zhu、Peng Zhang
DOI:10.1016/j.tetlet.2019.06.054
日期:2019.7
A new strategy for the synthesis of 2-Methylbenzofurans via the intramolecular Heckreaction has been developed. This efficient palladium-catalyzed system showed good catalytic activity. Various substituted 2-methylbenzofurans could be afforded in good to excellent yields.
[EN] TRIAZINE DERIVATIVES FOR TREATING DISEASES RELATING TO NEUROTROPHINS<br/>[FR] DÉRIVÉS TRIAZINE POUR LE TRAITEMENT DE MALADIES ASSOCIÉES À DES NEUROTROPHINES
申请人:ALZECURE PHARMA AB
公开号:WO2021038241A1
公开(公告)日:2021-03-04
There is provided a compound of formula I, (I) wherein R1 and R2 are as defined herein, which compounds are useful in the treatment of diseases characterised by impaired signalling of neurotrophins and/or other trophic factors, such as Alzheimer's disease and the like.